These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22825857)

  • 1. Sclerotherapy in an undetected pregnancy - a catastrophe?
    Reich-Schupke S; Leiste A; Moritz R; Altmeyer P; Stücker M
    Vasa; 2012 Jul; 41(4):243-7. PubMed ID: 22825857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke after varicose vein foam injection sclerotherapy.
    Forlee MV; Grouden M; Moore DJ; Shanik G
    J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
    Engelberger RP; Ney B; Clair M; Dabiri A; Alatri A; Mazzolai L; Kern P
    Vasa; 2016; 45(3):255-8. PubMed ID: 27129073
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.
    Van der Plas JP; Lambers JC; Van Wersch JW; Koehler PJ
    Lancet; 1994 Feb; 343(8894):428. PubMed ID: 7905592
    [No Abstract]   [Full Text] [Related]  

  • 10. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM
    J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
    Frullini A; Cavezzi A
    Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic neurological deficit after sclerotherapy.
    Trenkwalder P; Lydtin H
    Lancet; 1994 Mar; 343(8900):794. PubMed ID: 7907752
    [No Abstract]   [Full Text] [Related]  

  • 14. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
    Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolia cutis medicamentosa of the foot after sclerotherapy.
    Geukens J; Rabe E; Bieber T
    Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
    Fisher DA
    Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
    Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Eckmann DM; Kobayashi S
    J Vasc Surg; 2006 Jul; 44(1):225; author reply 225-6. PubMed ID: 16828455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.